TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

NCT06640582 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor
Brain Metastases
Brain Cancer
Glioma
Gliomas, Malignant
Glioblastoma
Meningioma

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
DRUG: Pembrolizumab

Sponsor

Essen Biotech